AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $9,496,000 | -60.2% | 11,813,000 | -62.2% | 0.00% | -72.7% |
Q1 2020 | $23,866,000 | -39.6% | 31,256,000 | -33.2% | 0.01% | -35.3% |
Q4 2019 | $39,499,000 | +0.3% | 46,756,000 | -2.1% | 0.02% | -10.5% |
Q3 2019 | $39,368,000 | +9.7% | 47,756,000 | +6.7% | 0.02% | +18.8% |
Q2 2019 | $35,898,000 | +37.3% | 44,756,000 | +49.2% | 0.02% | +23.1% |
Q1 2019 | $26,145,000 | +32.8% | 30,006,000 | +39.6% | 0.01% | +18.2% |
Q4 2018 | $19,691,000 | +151.4% | 21,500,000 | +186.7% | 0.01% | +266.7% |
Q3 2018 | $7,834,000 | +51.8% | 7,500,000 | +50.0% | 0.00% | 0.0% |
Q2 2018 | $5,160,000 | -59.0% | 5,000,000 | -59.0% | 0.00% | -57.1% |
Q1 2018 | $12,586,000 | -15.2% | 12,200,000 | -29.1% | 0.01% | -22.2% |
Q4 2017 | $14,844,000 | -52.4% | 17,200,000 | -46.2% | 0.01% | -62.5% |
Q3 2017 | $31,163,000 | -0.4% | 32,000,000 | -1.5% | 0.02% | -11.1% |
Q2 2017 | $31,295,000 | – | 32,500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |